These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15834925)
1. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Yang P; Kollmeyer TM; Buckner K; Bamlet W; Ballman KV; Jenkins RB Cancer; 2005 Jun; 103(11):2363-72. PubMed ID: 15834925 [TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
3. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895 [TBL] [Abstract][Full Text] [Related]
4. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411 [TBL] [Abstract][Full Text] [Related]
6. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Watanabe T; Nakamura M; Kros JM; Burkhard C; Yonekawa Y; Kleihues P; Ohgaki H Acta Neuropathol; 2002 Mar; 103(3):267-75. PubMed ID: 11907807 [TBL] [Abstract][Full Text] [Related]
7. Associations between ERCC2 polymorphisms and gliomas. Caggana M; Kilgallen J; Conroy JM; Wiencke JK; Kelsey KT; Miike R; Chen P; Wrensch MR Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):355-60. PubMed ID: 11319176 [TBL] [Abstract][Full Text] [Related]
8. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285 [TBL] [Abstract][Full Text] [Related]
10. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
12. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779 [TBL] [Abstract][Full Text] [Related]
13. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652 [TBL] [Abstract][Full Text] [Related]
14. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Kuschel B; Chenevix-Trench G; Spurdle AB; Chen X; Hopper JL; Giles GG; McCredie M; Chang-Claude J; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1828-31. PubMed ID: 16030124 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333 [TBL] [Abstract][Full Text] [Related]
16. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879 [TBL] [Abstract][Full Text] [Related]
17. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Rubio MP; Correa KM; Ueki K; Mohrenweiser HW; Gusella JF; von Deimling A; Louis DN Cancer Res; 1994 Sep; 54(17):4760-3. PubMed ID: 8062276 [TBL] [Abstract][Full Text] [Related]
18. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Yin J; Vogel U; Ma Y; Qi R; Wang H Mutat Res; 2008 May; 641(1-2):12-8. PubMed ID: 18358500 [TBL] [Abstract][Full Text] [Related]